A group of engineers and clinicians from the University of Wisconsin-Madison are working on a device that would help remove some of the pain associated with breast tumor removal. A radio frequency identification (RFID) tag would replace the localization wire surgeons insert into the breast to help mark the location of a tumor or benign mass on the day of surgery. The group working on the project also expects the RFID tag procedure to increase accuracy and reduce costs in comparison to the localization wire system.
The UW-Madison team involved in developing the new RFID procedure, including professor of surgery and director of the UW Health Breast Center, Lee Wilke, MD, have founded the company Elucent Medical to commercialize the device. The company recently won the 2014 Wisconsin Governor’s Business Plan Contest.